Join us for the Launch Session 

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine 

on the occasion of ECR 2021 
 

Thursday, March 4, 2021 | 11:45-12:45 (CET) 

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine was established in 2018 with the aim to examine global access to imaging and nuclear medicine for cancer care as well as to analyse barriers to access to imaging for cancer care. New evidence is provided to demonstrate the benefits of imaging in improving cancer care and cancer survival and recommendations on how best to introduce and scale up imaging services in health systems are presented.

Access to the session is free of charge, no ECR 2021 ticket is required. 

How to register for the session:

  1. Visit the session page on ESR Connect
  2. Click on ‚Login’ in the upper right corner and enter your ESR MyUserArea credentials or create a new ESR account for free (after you have created your account please visit the session page once again)
  3. The session is now saved in your user menu under 'My Courses' which can be accessed via your user icon in the upper right corner

Session Programme

Ensuring sustainable healthcare systems: The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine

Thursday, March 4, 2021 | 11:45-12:45 (CET)

  • Moderator
    David Collingridge, Editor-in-Chief, The Lancet Oncology, London/UK
     
  • Goals and scope of The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine (10 min)
    May Abdel Wahab, Director, IAEA Division of Human Health, Vienna/AT
     
  • Global utilization of imaging and nuclear medicine in oncology (10 min)
    Andrew Scott, Director of the Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC/AU
     
  • Health economic analysis of cancer imaging (10 min)
    Rifat Atun; Professor, Department of Global Health and Population, Harvard TH Chan School of Public Health,Boston, MA/US
     
  • Overview and recommendations (10 min)
    Hedvig Hricak; Chairman of the Department of Radiology at Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY/US
     
  • Live Q&A (15 min)
     

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine is supported by the following 27 organizations: the African Association of Nuclear Medicine, the American College of Radiology, the Association of Latin American Societies of Biology and Nuclear Medicine, the Australian and New Zealand Society of Nuclear Medicine, the Asia Oceania Federation of Nuclear Medicine and Biology, the African Organisation for Research & Training in Cancer, the American Society of Clinical Oncology, the Arab Society of Nuclear Medicine, the African Society of Radiology, the American Society for Radiation Oncology, the Breast Cancer Research Foundation, the European Association of Nuclear Medicine, the European Society for Medical Oncology, the European Society of Radiology, the European Society for Radiotherapy and Oncology, the Hong Kong College of Radiologists, the International Atomic Energy Agency, the International Society for Strategic Studies in Radiology, the International Society of Radiology, the National Cancer Institute, the Pan-Arab Association of Radiological Societies, the Radiological Society of North America, the South African Society of Nuclear Medicine, the Society of Nuclear Medicine & Molecular Imaging, the Union for International Cancer Control, the World Federation of Nuclear Medicine and Biology, and the World Molecular Imaging Society.